인공 추간판 치환 시장 규모, 점유율 및 동향 분석 보고서 : 재료별, 적응증별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Artificial Disc Replacement Market Summary

The global artificial disc replacement market size was estimated at USD 686.8 million in 2025 and is expected to reach USD 1,329.4 million in 2033, growing at a CAGR of 8.7% from 2026 to 2033. The growth is driven by the rising incidence of degenerative spinal disorders, influenced by sedentary lifestyles, obesity, and increasing cases of work-related spinal strain.

Technological advancements in motion-preserving implants, including enhanced biomaterials and minimally invasive surgical approaches, are improving clinical outcomes and accelerating adoption. In addition, there is a growing shift toward motion-preservation procedures over spinal fusion, as both patients and surgeons increasingly prefer treatments that maintain spinal mobility and reduce the risk of adjacent segment degeneration, further supporting the growth of the artificial disc replacement industry.

The section below outlines the key factors driving the growth of the artificial disc replacement (ADR) market, highlighting the rising burden of degenerative disc disease and spinal disorders, as well as the growing body of long-term clinical evidence. It also highlights technological advancements in artificial disc replacement.

Global Artificial Disc Replacement Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial disc replacement market report based on material type, indication, end use, and region:

• Material Type Outlook (Revenue, USD Million, 2021 - 2033)
• Metal-on-Polymer (MoP)
• Metal-on-Metal (MoM)
• Polymer-Based / Elastomeric
• Others (Ceramic / Hybrid)
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Cervical Disc Replacement
• Lumbar Disc Replacement
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material Type
  • 1.2.2. Indication
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material type outlook
  • 2.2.2. Indication outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Landscape

Chapter 3. Artificial Disc Replacement Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Burden of Degenerative Disc Disease and Spinal Disorders
    • 3.2.1.2. Growing Surgeon & Patient Preference for Minimally Invasive Disc Arthroplasty over Spinal Fusion
    • 3.2.1.3. Increasing Long-Term Clinical Evidence Boosts Adoption of Artificial Disc Replacement
    • 3.2.1.4. Technological Advances in Artificial Disc Replacement
      • 3.2.1.4.1. Viscoelastic Disc Implants Mimicking Native Biomechanics
      • 3.2.1.4.2. Biomimetic Disc Design Principles Guiding Next Gen Implants
      • 3.2.1.4.3. Material and Surgical Innovations
      • 3.2.1.4.4. Clinical Implications and Future Directions
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent Regulatory Approval & Product Recall
    • 3.2.2.2. Limited Insurance Coverage and Reimbursement
• 3.3. Artificial Disc Replacement Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Market Consolidation & Strategic Restructuring
    • 3.3.3.1. Timeline of consolidation, acquisitions, and divestitures
    • 3.3.3.2. Strategic industry shift: exits & refocusing by medtech giants
    • 3.3.3.3. Consolidation, discontinuations & legacy product attrition
    • 3.3.3.4. Competitive & innovation impacts on ADR
    • 3.3.3.5. Implications for ADR market structure
  • 3.3.4. Technology Evolution (Generational Shift)
    • 3.3.4.1. First-generation ADR mechanical articulation systems
    • 3.3.4.2. Second-generation ADR material optimization & stability enhancement
    • 3.3.4.3. Third-generation ADR biomimetic & viscoelastic systems
    • 3.3.4.4. Emerging fourth wave: intelligent & personalized ADR systems (pipeline)
    • 3.3.4.5. Strategic interpretation of technology evolution
  • 3.3.5. Market Opportunity Analysis
    • 3.3.5.1. Untapped patient pool
    • 3.3.5.2. Geographic expansion
    • 3.3.5.3. Global regional opportunity assessment
    • 3.3.5.4. Indication expansion
    • 3.3.5.5. Incremental opportunity drivers
  • 3.3.6. Pipeline Analysis

Chapter 4. Artificial disc replacement Market: Material Type Estimates & Trend Analysis

• 4.1. Global Artificial Disc Replacement Market: Material Type Dashboard
• 4.2. Global Artificial Disc Replacement Market: Material Type Movement Analysis
• 4.3. Global Artificial Disc Replacement Market by Material Type, Revenue
• 4.4. Metal-on-Polymer (MoP)
  • 4.4.1. Metal-on-Polymer (MoP)market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Metal-on-Metal (MoM)
  • 4.5.1. Metal-on-Metal (MoM) market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Polymer-Based / Elastomeric
  • 4.6.1. Polymer-Based / Elastomeric market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Artificial Disc Replacement Market: Indication Estimates & Trend Analysis

• 5.1. Global Artificial Disc Replacement Market: Indication Dashboard
• 5.2. Global Artificial Disc Replacement Market: Indication Movement Analysis
• 5.3. Global Artificial Disc Replacement Market Estimates and Forecasts, By Indication, Revenue (USD Million)
• 5.4. Cervical Disc Replacement
  • 5.4.1. Cervical Disc Replacement market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Lumbar Disc Replacement
  • 5.5.1. Lumbar Disc Replacement market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Artificial Disc Replacement Market: End Use Estimates & Trend Analysis

• 6.1. Global Artificial Disc Replacement Market: End Use Dashboard
• 6.2. Global Artificial Disc Replacement Market: End Use Movement Analysis
• 6.3. Global Artificial Disc Replacement Market Estimates and Forecasts, by End Use, Revenue (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient facilities market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Artificial Disc Replacement Market: Regional Estimates & Trend Analysis by Material Type, Indication, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key customers
  • 8.2.3. Key company market share analysis, 2023
  • 8.2.4. Medtronic, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Normmed Medical.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Globus Medical, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Dymicron, Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. HIGHRIDGE MEDICAL
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. AxioMed LLC
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Neuro France Implants
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. SpineArt SA
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Synergy Spine Solutions Inc.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Centinel Spine, LLC
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. Aditus Medical
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. B Braun Melsungen
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Product benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Spineway Group
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Product benchmarking
    • 8.2.16.4. Strategic initiatives
  • 8.2.17. Prodorth Spine
    • 8.2.17.1. Company overview
    • 8.2.17.2. Financial performance
    • 8.2.17.3. Product benchmarking
    • 8.2.17.4. Strategic initiative
  • 8.2.18. SIGNUS Medizintechnik GmbH
    • 8.2.18.1. Company overview
    • 8.2.18.2. Financial performance
    • 8.2.18.3. Product benchmarking
    • 8.2.18.4. Strategic initiatives